Failure in the management of missed doses under various scenarios during treatment with antipsychotic medications might lead to a relapse of schizophrenia. Systems pharmacology and pharmacometric modeling and simulation have become increasingly important in accelerating drug development and regulatory approval nevertheless, their use in precision pharmacotherapy and management of missed doses remain scarce.
